Landmark TrialRCTRandomized Controlled Trial
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
New England Journal of Medicine2009IF: 25.4
Sam Schulman, Clive Kearon, Ajay K. Kakkar, Patrick Mismetti, Sebastian Schellong, Henry Eriksson, David Baanstra, Janet Schnee, Samuel Z. Goldhaber
Abstract
For the treatment of acute venous thromboembolism, a fixed dose of dabigatran is as effective as warfarin, has a safety profile that is similar to that of warfarin, and does not require laboratory monitoring. (ClinicalTrials.gov number, NCT00291330.)